hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer
Journal of International Medical Research · 2023
DOI: 10.1177/03000605231163780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Medical Research, 2023. Verfasst von Xiao-Qian Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Xingtai People Hospital of Hebei Medical University, Xingtai, China. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Cisplatin, E2F1 Transcription Factor, Ovarian Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To explore underlying mechanisms that regulate hMSH2 expression and drug susceptibility in epithelial ovarian cancer (EOC).
Methods
Using data from the Cancer Genome Atlas (TCGA) we used bioinformatical analysis to predict transcription factors (TFs) that potentially regulate hMSH2. RT-qPCR, Western blot, and luciferase assays were undertaken using ovarian cancer cell lines to verify the identified TF. Expressions of the TF were modulated using overexpression or knockdown, and the corresponding cellular responses to cisplatin were examined.
Results
The TF, E2F1, was found to regulate the hMSH2 gene. The expression level of E2F1 correlated with cisplatin susceptibility in vitro. Kaplan-Meier analysis of 77 patients with EOC showed that low E2F1 expression was associated with worse survival.
Conclusions
To our knowledge, this is the first report of E2F1 regulated MSH2 expression playing a role in drug resistance of platinum-based treatments for patients with EOC. Further work is need to confirm our results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Xingtai People Hospital of Hebei Medical University, Xingtai, China.
- Department of Gynaecology, Affiliated Xingtai People Hospital of Hebei Medical, University, Xingtai, China.
ORCID-Profile: Tian Hua
Zitieren
APA
Hu, X. Q., Zhang, B. Y., & Hua, T. (2023). hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer. Journal of International Medical Research. https://doi.org/10.1177/03000605231163780
Vancouver
Hu XQ, Zhang BY, Hua T. hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer. Journal of International Medical Research. 2023. doi:10.1177/03000605231163780
BibTeX
@article{Hu2023,
author = {Hu, Xiao-Qian and Zhang, Bao-Ying and Hua, Tian},
title = {hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer},
journal = {Journal of International Medical Research},
year = {2023},
doi = {10.1177/03000605231163780}
}
EUVIMED